Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Changchun BCHT Biotechnology C (688276 CH)
Watchlist
42
Analysis
Health Care
•
China
Changchun BCHT Biotechnology Co. Ltd. operates as a high-tech biopharmaceutical company. The Company provides human vaccine researching, development, production, and sales services. Changchun BCHT Biotechnology markets its products throughout China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Qingdao Haier Biomedical Lt
•
07 Dec 2022 08:56
STAR50 Index Rebalance Preview: Another Five Potential Changes in March
There could be 5 changes using a 6-month minimum listing history. One-way turnover will be 5%+ resulting in a one-way trade of CNY4bn. Impact on...
Brian Freitas
Follow
743 Views
Share
bullish
•
Shanghai United Imaging Health
•
26 Nov 2022 15:07
STAR50 Index Rebalance: Adds Outperform Deletes in the Last Week
There are 5 changes for the STAR50 in Dec. The changes were forecast; the adds have outperformed the deletes in the last week. Historically, a long...
Brian Freitas
Follow
772 Views
Share
bullish
•
SICC
•
25 Oct 2022 04:50
STAR50 Index Rebalance Preview: Stable Long/Short Performance in a Volatile Market
We expect the index committee to continue using a 6-month minimum listing history. That means 5 changes in December. The potential adds have...
Brian Freitas
Follow
706 Views
Share
bullish
•
Shanghai United Imaging Health
•
13 Sep 2022 01:25
STAR50 Index Rebalance Preview: Four or Five Changes in December
There could be 4/5 changes if a 12/6 month minimum listing history is used. Using a 6 month minimum listing history, one-way turnover is estimated...
Brian Freitas
Follow
680 Views
Share
bullish
•
Hoymiles Power Electronics
•
27 Aug 2022 09:34
STAR50 Index Rebalance: Adds Continue to Outperform as Changes Are Announced
There are 5 changes to the STAR50 in September as the index committee sticks to a 6 month minimum listing history. The adds have outperformed the...
Brian Freitas
Follow
855 Views
Share
First
Previous
3
4
5
6
7
8
9
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x